These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7381854)

  • 1. Structure--antitubulin activity relationship in steganacin congeners and analogues. Inhibition of tubulin polymerization in vitro by (+/-)-isodeoxypodophyllotoxin.
    Zavala F; Guenard D; Robin JP; Brown E
    J Med Chem; 1980 May; 23(5):546-9. PubMed ID: 7381854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tubulin binding affinities of podophyllotoxin and colchicine analogues.
    Kelleher JK
    Mol Pharmacol; 1977 Mar; 13(2):232-41. PubMed ID: 854021
    [No Abstract]   [Full Text] [Related]  

  • 3. Antimitotic and antitubulin activity of the tumor inhibitor steganacin.
    Wang RW; Rebhum LI; Kupchan SM
    Cancer Res; 1977 Sep; 37(9):3071-9. PubMed ID: 560248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of 2-diazo-3,3,3-trifluopropanoyl derivatives of colchicine and podophyllotoxin as photoaffinity labels: reactivity, photochemistry, and tubulin binding.
    Hahn KM; Hastie SB; Sundberg RJ
    Photochem Photobiol; 1992 Jan; 55(1):17-27. PubMed ID: 1603847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Podophyllotoxin, steganacin and combretastatin: natural products that bind at the colchicine site of tubulin.
    Sackett DL
    Pharmacol Ther; 1993 Aug; 59(2):163-228. PubMed ID: 8278462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of tubulin-binding and antitumor activities of podophyllotoxin analogs.
    Kelleher JK
    Cancer Treat Rep; 1978 Oct; 62(10):1443-7. PubMed ID: 101303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs that inhibit tubulin polymerization: the particular case of podophyllotoxin and analogues.
    Desbène S; Giorgi-Renault S
    Curr Med Chem Anticancer Agents; 2002 Jan; 2(1):71-90. PubMed ID: 12678752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and cytotoxicity of racemic isodeoxypodophyllotoxin analogues with isoprene-derived side chains.
    Zhao Y; Feng JH; Ding HX; Xiong Y; Cheng CH; Hao XJ; Zhang YM; Pan YJ; Guéritte F; Wu XM; Bai H; Stöckigt J
    J Nat Prod; 2006 Aug; 69(8):1145-52. PubMed ID: 16933865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [4-Aza-2,3-didehydropodophyllotoxins: new lignan with antitumor activity obtained from one-step synthesis].
    Giorgi-Renault S
    Ann Pharm Fr; 2005 Jan; 63(1):63-8. PubMed ID: 15803102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podophyllotoxin-resistant mutants of Chinese hamster ovary cells: cross-resistance studies with various microtubule inhibitors and podophyllotoxin analogues.
    Gupta RS
    Cancer Res; 1983 Feb; 43(2):505-12. PubMed ID: 6848174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of podophyllotoxin congeners as tubulin polymerization inhibitors.
    Kamal A; Srinivasa Reddy T; Polepalli S; Shalini N; Reddy VG; Subba Rao AV; Jain N; Shankaraiah N
    Bioorg Med Chem; 2014 Oct; 22(19):5466-75. PubMed ID: 25131956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and Biochemical Characterization of the Interaction of Tubulin with Potent Natural Analogues of Podophyllotoxin.
    Antúnez-Mojica M; Rodríguez-Salarichs J; Redondo-Horcajo M; León A; Barasoain I; Canales Á; Cañada FJ; Jiménez-Barbero J; Alvarez L; Díaz JF
    J Nat Prod; 2016 Aug; 79(8):2113-21. PubMed ID: 27518758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirements for P-glycoprotein recognition based on structure-activity relationships in the podophyllotoxin series.
    Etievant C; Schambel P; Guminski Y; Barret JM; Imbert T; Hill BT
    Anticancer Drug Des; 1998 Jun; 13(4):317-36. PubMed ID: 9627671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity study of the inhibition of microtubule assembly in vitro by podophyllotoxin and its congeners.
    Loike JD; Brewer CF; Sternlicht H; Gensler WJ; Horwitz SB
    Cancer Res; 1978 Sep; 38(9):2688-93. PubMed ID: 679171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discover 4β-NH-(6-aminoindole)-4-desoxy-podophyllotoxin with nanomolar-potency antitumor activity by improving the tubulin binding affinity on the basis of a potential binding site nearby colchicine domain.
    Zhao W; He L; Xiang TL; Tang YJ
    Eur J Med Chem; 2019 May; 170():73-86. PubMed ID: 30878833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replacement of the lactone moiety on podophyllotoxin and steganacin analogues with a 1,5-disubstituted 1,2,3-triazole via ruthenium-catalyzed click chemistry.
    Imperio D; Pirali T; Galli U; Pagliai F; Cafici L; Canonico PL; Sorba G; Genazzani AA; Tron GC
    Bioorg Med Chem; 2007 Nov; 15(21):6748-57. PubMed ID: 17765552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morpholino derivatives of benzyl-benzodioxole, a study of structural requirements for drug interactions at the colchicine/podophyllotoxin binding site of tubulin.
    Batra JK; Jurd L; Hamel E
    Biochem Pharmacol; 1986 Nov; 35(22):4013-8. PubMed ID: 3778522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of piperazine acetate podophyllotoxin ester derivatives targeting tubulin depolymerization as new anticancer agents.
    Sun WX; Ji YJ; Wan Y; Han HW; Lin HY; Lu GH; Qi JL; Wang XM; Yang YH
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4066-4074. PubMed ID: 28757065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podophyllotoxin analogs. 1. Synthesis and biological evaluation of certain trans-2-aryl-trans-6-hydroxymethyl-3-cyclohexenecarboxylic acid gamma-lactones as antimitotic agents.
    Smissman EE; Murray RJ; McChesney JD; Houston LL; Pazdernik TL
    J Med Chem; 1976 Jan; 19(1):148-53. PubMed ID: 812990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-function studies with derivatives of 6-benzyl-1,3-benzodioxole, a new class of synthetic compounds which inhibit tubulin polymerization and mitosis.
    Batra JK; Jurd L; Hamel E
    Mol Pharmacol; 1985 Jan; 27(1):94-102. PubMed ID: 3965931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.